These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16941571)

  • 1. Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma.
    Wang JX; Yu JK; Wang L; Liu QL; Zhang J; Zheng S
    Proteomics; 2006 Oct; 6(19):5344-9. PubMed ID: 16941571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of serum protein fingerprint model and support vector machine in diagnosis of thyroid cancer].
    Wang JX; Wang L; Fan YZ; Liu QL; Zhang J; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):979-82. PubMed ID: 16759540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection and identification of specific serum biomarkers in papillary thyroid cancer].
    Wang JX; Dong R; Liu QL; Yang SB; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):265-8. PubMed ID: 19615280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK.
    He H; Sun G; Ping F
    Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(5):208-13. PubMed ID: 19735007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
    Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
    Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study using SELDI-TOF-MS based proteomic profile for the identification of diagnostic biomarkers of thyroid proliferative diseases.
    Suriano R; Lin Y; Ashok BT; Schaefer SD; Schantz SP; Geliebter J; Tiwari RK
    J Proteome Res; 2006 Apr; 5(4):856-61. PubMed ID: 16602693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of papillary thyroid carcinoma with serum protein profile analysis.
    Moretz WH; Gourin CG; Terris DJ; Xia ZS; Liu Z; Weinberger PM; Chin E; Adam BL
    Arch Otolaryngol Head Neck Surg; 2008 Feb; 134(2):198-202. PubMed ID: 18283164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of renal allograft subclinical rejection by urine protein fingerprint analysis.
    Mao Y; Yu J; Chen J; Yang H; He Q; Shou Z; Wu J; Zheng S
    Transpl Immunol; 2008 Jan; 18(3):255-9. PubMed ID: 18047934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fine needle aspiration biopsy in the diagnosis of thyroid neoplasms].
    Ravetto C
    Chir Ital; 1994; 46(4):8-11. PubMed ID: 7882452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
    Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
    Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor.
    Liu J; Zheng S; Yu JK; Zhang JM; Chen Z
    J Zhejiang Univ Sci B; 2005 Jan; 6(1):4-10. PubMed ID: 15593384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
    Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detecting biomarkers from serum in nephroblastoma patients with support vector machine].
    Wang JX; Zhang J; Liu QL; Wang L; Fan YZ; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2982-5. PubMed ID: 17288811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Immunoproteomics Combined With Pathological Reassessment of Surgical Specimens Identifies TCP-1ζ Autoantibody as a Potential Biomarker in Thyroid Neoplasia.
    Belousov PV; Bogolyubova AV; Kim YS; Abrosimov AY; Kopylov AT; Tvardovskiy AA; Lanshchakov KV; Sazykin AY; Dvinskikh NY; Bobrovskaya YI; Selivanova LS; Shilov ES; Schwartz AM; Shebzukhov YV; Severskaia NV; Vanushko VE; Moshkovskii SA; Nedospasov SA; Kuprash DV
    J Clin Endocrinol Metab; 2015 Sep; 100(9):E1206-15. PubMed ID: 26196948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcarcinoma of the thyroid.
    Baloch ZW; LiVolsi VA
    Adv Anat Pathol; 2006 Mar; 13(2):69-75. PubMed ID: 16670460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
    Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Using ANN and serum protein pattern models in liver cancer diagnosis].
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):189-92. PubMed ID: 15854466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cytokeratins determination in differentiated thyroid carcinoma.
    Appetecchia M; Meçule A; Ducci M; Palma L; Castelli M
    J Exp Clin Cancer Res; 2001 Jun; 20(2):253-6. PubMed ID: 11484983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
    Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.